Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Deferiprone and Deferasirox vs DFP and DFO in Severe Iron Overload
NCT01511848Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of deferasirox in iron overload (2 arms), sponsored by Ain Shams University. Primary endpoint: Change in Serum Ferritin Level at 12 months. Status: unknown.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01511848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511848.